Biotechnology company developing antibodies targeting receptors that modulate the activity of immune effector cells involved in inflammation and tissue damage.

Sectors
Healthcare
Life Sciences
First Invested
2017
Growth
Company Status
IPO/Public
NASDAQ: ALLK
Board Members
Paul Walker
Associated Team
Lulu Xu